Skip to main content

Press releases

For all media enquiries, please contact us

Rx Propellant

Actis acquires RX Propellant a leading real estate platform providing solutions to tenants in the life sciences sector in India

London, Mumbai 23 May 2022: Actis, a global investor in sustainable infrastructure, has acquired Rx Propellant, a platform focused on providing real estate solutions (R&D labs and associated fac…

Read article

Actis reaches final close on Actis Asia Real Estate 2 with more than US$700million of investable capital

06 April 2022